144 related articles for article (PubMed ID: 20596253)
1. E-cadherin promoter hypermethylation may contribute to protein inactivation in pterygia.
Young CH; Chiu YT; Shih TS; Lin WR; Chiang CC; Chou YE; Cheng YW; Tsai YY
Mol Vis; 2010 Jun; 16():1047-53. PubMed ID: 20596253
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
[TBL] [Abstract][Full Text] [Related]
4. CyclinD1 protein expressed in pterygia is associated with β-catenin protein localization.
Tung JN; Chiang CC; Tsai YY; Chou YY; Yeh KT; Lee H; Cheng YW
Mol Vis; 2010 Dec; 16():2733-8. PubMed ID: 21179427
[TBL] [Abstract][Full Text] [Related]
5. [Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma].
Li C; Dong J; Chen MQ; Li WL; Ren JY; Chen SX; Li QT; Geng JW; Miao YD; Yang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):538-41. PubMed ID: 21792768
[TBL] [Abstract][Full Text] [Related]
6. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma].
Li Z; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.
Bhagat R; Premalata CS; Shilpa V; Pallavi VR; Ramesh G; Vijay CR; Krishnamoorthy L
Tumour Biol; 2013 Aug; 34(4):2459-68. PubMed ID: 23605324
[TBL] [Abstract][Full Text] [Related]
8. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalisation of E-cadherin and beta-catenin in human pterygium.
Kase S; Osaki M; Sato I; Takahashi S; Nakanishi K; Yoshida K; Ito H; Ohno S
Br J Ophthalmol; 2007 Sep; 91(9):1209-12. PubMed ID: 17360734
[TBL] [Abstract][Full Text] [Related]
10. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
11. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
14. Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer.
Winter JM; Ting AH; Vilardell F; Gallmeier E; Baylin SB; Hruban RH; Kern SE; Iacobuzio-Donahue CA
Clin Cancer Res; 2008 Jan; 14(2):412-8. PubMed ID: 18223216
[TBL] [Abstract][Full Text] [Related]
15. [Unusual expression and molecular mechanisms of E-cadherin, beta-catenin in correlation with clinicopathologic parameters in neuroblastoma].
Wu XR; Zhu MH; Zhang ZD; Yin MZ; Xi ZJ; Zhang FY; Zhang WZ
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):155-9. PubMed ID: 17535680
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium.
Kato N; Shimmura S; Kawakita T; Miyashita H; Ogawa Y; Yoshida S; Higa K; Okano H; Tsubota K
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1511-7. PubMed ID: 17389479
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
